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N-alkyl perfluorooctane sulfonamides have been widely used as surfactants on fabrics and papers, fire retardants, and anti-corrosion agents,
among many other commercial applications. The global distribution and environmental persistence of these compounds has generated considerable
interest regarding potential toxic effects. We have previously reported that perfluorooctanesulfonamidoacetate (FOSAA) and N-ethylperfluor-
ooctanesulfonamidoacetate (N-EtFOSAA) induce themitochondrial permeability transition (MPT) in vitro. In this studywe tested the hypothesis that
FOSAA and N-EtFOSAA interact with the adenine nucleotide translocator (ANT) resulting in a functional inhibition of the translocator and
induction of the MPT. Respiration and membrane potential of freshly isolated liver mitochondria from Sprague–Dawley rats were measured using
an oxygen electrode and a tetraphenylphosphonium-selective (TPP+) electrode, respectively. Mitochondrial swelling was measured spectro-
photometrically. The ANT ligands bongkregkic acid (BKA) and carboxyatractyloside (cATR) inhibited uncoupling of mitochondrial respiration
caused by 10 μM N-EtFOSAA, 40 μM FOSAA, and the positive control 8 μM oleic acid. ADP-stimulated respiration and depolarization of
mitochondrial membrane potential were inhibited by cATR, FOSAA, N-EtFOSAA, and oleic acid, but not by FCCP. BKA inhibited calcium-
dependent mitochondrial swelling induced by FOSAA, N-EtFOSAA, and oleic acid. Seventy-five micromolar ADP also inhibited swelling induced
by the test compounds, but cATR induced swelling was not inhibited by ADP. Results of this investigation indicate that N-acetyl perfluorooctane
sulfonamides interact directly with the ANT to inhibit ADP translocation and induce the MPT, one or both of which may account for the metabolic
dysfunction observed in vivo.
© 2007 Elsevier Inc. All rights reserved.Keywords: Adenine nucleotide translocator; Perfluorooctane sulfonamides; MPTIntroduction
N-alkyl perfluorooctane sulfonamides are a class of environ-
mentally persistent compounds that have been in production since
the late 1940s and early 1950s. Perfluorooctane sulfonic acid
(PFOS) and the related sulfonamides N-acetyl-perfluorooctane
sulfonamide (FOSAA) and N-ethylperfluorooctanesulfonami-
doacetate (N-EtFOSAA) have been widely used as surfactants
in numerous commercial and industrial applications (Giesy and
Kannan, 2002). Because the fluorine–carbon bonds impart struc-
tural stability, the perfluorooctanes are resistant to hydrolysis,
photolysis, microbial degradation, as well as metabolism and
consequently are extremely persistent in the environment (Shaba-⁎ Corresponding author. Fax: +1 218 726 8014.
E-mail address: obri0150@d.umn.edu (T.M. O'Brien).
0041-008X/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.taap.2007.10.016lina et al., 1999; Giesy and Kannan, 2002). The structures of the
test compounds are depicted in Table 1.
The source, distribution, and fate of perfluorooctanes in the
environment are still not completely understood, but PFOS has
been detected in surface waters (Hansen et al., 2002; Moody
et al., 2003; Saito et al., 2004), and in the serum of birds, fish,
and mammals worldwide (Key et al., 1998; Giesy and Kannan,
2002; Kannan et al., 2002; Martin et al., 2004). PFOS is a
terminal degradation product of more complex sulfonamides,
and it is suspected that a component of the total PFOS detected
in the environment is a result of the degradation of the sub-
stituted N-alkyl perfluorooctane sulfonamides such as FOSAA
and N-EtFOSAA (Martin et al., 2002; Olsen et al., 2003).
Whole animal studies have shown that there is a wide profile
of acute and subchronic high dose effects of perfluorinated acids
in adult rodents and monkeys that include hepatocellular
Table 1
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hepatomegaly, decreased body weight, and death (Goldenthal
et al., 1978; Van Rafelghem et al., 1987; Vanden Heuvel et al.,
1991; Seacat et al., 2002). It has also been reported that ex-
posure of rodents to perfluorinated acids during gestation results
in reduced birth weights and a profound neonatal morbidity
(Case et al., 2001; Thibodeaux et al., 2003; Luebker et al.,
2005). Inhibition of mitochondrial respiration and impairment
of β-oxidation of fatty acids, as a result of uncoupling of oxi-
dative phosphorylation or the induction of the MPT, have been
implicated in a variety of pathologies related to disrupted lipid
metabolism and hepatotoxicity (Jaeschke et al., 2002). The dose
dependent metabolic disruption reported in all of these studies
suggests a potential role for mitochondrial dysfunction in the
underlying mechanism of toxicity (Starkov and Wallace, 2002).
Free fatty acids such as oleic and palmitic acid have been
shown to uncouple oxidative phosphorylation in isolated rat
liver mitochondria through a mechanism that involves cycling
of protons across the inner mitochondrial membrane (Schonfeld
et al., 2003). It is hypothesized that the weak uncoupling effect
of fatty acids makes mitochondria more susceptible to the MPT
by lowering mitochondrial membrane potential (Δψ) to values
close to what is referred to as the MPT gating potential (Petro-
nilli et al., 1994; Bernardi et al., 2002). One component of the
uncoupling mechanism appears to require the conjugate base be
shuttled back to the inner membrane space through a process
that apparently involves mitochondrial anion carriers such as
the adenine nucleotide translocator (ANT) (Skulachev, 1991) or
dicarboxylate carrier (Schonfeld et al., 1997; Wieckowski and
Wojtczak, 1997). The ANT is further implicated in this tran-
sporter mediated mechanism by the fact that specific ligands of
the ANT, carboxyatractyloside (cATR) and bongkrekic acid
(BKA) suppress fatty acid induced uncoupling of mitochondrial
respiration (Schonfeld, 1990; Skulachev, 1998).We have reported that FOSAA and N-EtFOSAA are potent
inducers of theMPT,which results in the release of cytochrome c,
inhibition of respiration, and the generation of reactive oxy-
gen species (O'Brien and Wallace, 2004). Furthermore, we have
shown that the induction of the MPT is preceded by an initial
partial depolarization of the mitochondrial membrane potential
(Δψ) which is the result of a translocation of charge across the
inner mitochondrial membrane (O'Brien et al., 2006). These
previous studies have described the outcome of exposure of
isolated mitochondria to the test compounds without identifying
the triggering mechanisms and how these mechanisms relate to
the observed disruption of mitochondrial bioenergetics.
The purpose of the current investigation was to test the hy-
pothesis that FOSAA and N-EtFOSAA, like the non-fluorinated
fatty acids, interact directly with the ANT, which results in a
functional inhibition of the translocase activity and induction of
the MPT. In order to test this hypothesis we investigated the
effect of known ANT ligands BKA and cATR on the alterations
of mitochondrial bioenergetics induced by N-acetyl perfluor-
ooctane sulfonamides: uncoupling of oxidative phosphoryla-
tion, decrease in membrane potential, and calcium-induced
swelling.
Materials and methods
Reagents. All fluorochemical compounds were synthesized, characterized,
and provided gratis by the 3M Company, St. Paul, MN. Cyclosporin A was
provided as a generous gift of Sandoz Pharmaceuticals (East Hanover, NJ, www.
sandoz.com), Ultra Pure sucrose was purchased from ICN Biomedicals, Inc.
(Aurora, OH, www.icnbiomed.com), and all other reagents were from Sigma-
Aldrich (St. Louis, MO, www.sigma-aldrich.com).
Solubility of the perfluorooctane sulfonamides in aqueous media. The perfluor-
ooctane sulfonamide and oleic acid stock solutions were all prepared at 10 mM in
dimethylsulfoxide (DMSO). Concern about test compound solubility in aqueous
media has been considered thoroughly in our experimental design as previously
reported (O'Brien et al., 2006). To maximize partitioning to the mitochondrial
fraction of the reaction all experiments were run in a continuously mixed reaction
chamber at 30 °C. The concentrations of the test compound used in each particular
assay were chosen to very subtly characterize the underlying mechanism of the
observed effect. For example the concentration required to induce the MPT by
FOSAA is far greater than that required to induce slight uncoupling of mito-
chondrial respiration.
Mitochondrial isolation. Mitochondria were isolated from liver of adult male
Sprague–Dawley rats (125–250 g body weight) by differential centrifugation
(Zhou and Wallace, 1999). Rats were purchased from Harlan Sprague–Dawley
(Madison, WI) and acclimated in an AAALAC-accredited, climate-controlled
animal-care facility for at least 3 days and fasted for 12–18 h prior to the
experiment. Animals were euthanized in a CO2 chamber followed by deca-
pitation. The mitochondria were isolated and prepared as previously described
(Starkov and Wallace, 2002; O'Brien and Wallace, 2004). Mitochondrial pellet
protein concentration was determined with the Bradford assay using bovine
serum albumin as a standard (Bradford, 1976).
Mitochondrial swelling. Changes in mitochondrial volume were estimated by
variations in light scattering as monitored spectrophotometrically at 540 nm as
previously described (Henry and Wallace, 1995; Starkov and Wallace, 2002;
O'Brien and Wallace, 2004). Briefly, mitochondria were energized with 5 mM
succinate for 2 min before adding 25 μM CaCl2 followed 2 min later by the
addition of 40 μM FOSAA, 6 μM N-EtFOSAA, 8 μM oleic acid (Fig. 1), or
5 μM cATR (Fig. 2). Where indicated, 1 μM of the MPT inhibitor cyclosporin A
(CsA) (Broekemeier et al., 1989) was added just prior to succinate, plus 5 μM of
Fig. 1. Swelling of rat liver mitochondria was monitored by light scattering at 540 nm in the presence and absence of 5 μM bongkrekic acid (BKA) or 1 μM CsA.
(A) Mitochondrial swelling traces are representative of 3 repetitions, each using mitochondrial preparations from separate animals. 8 μM oleic acid (OA)±BKA;
40 μM FOSAA±BKA; 6 μM N-Et-FOSAA±BKA. (B) Oleic acid, FOSAA, and N-EtFOSAA induced a decrease in absorbance measured at 540 nM. Results
reported as change in arbitrary absorbance units 6 min after the addition of the test compound. The concentrations and additions are as reported in panel A. Bars
represent the mean±S.E.M. of 3 repetitions each analyzed by 2-way ANOVA and Tukey's post hoc test. (⁎) Statistically significant difference compared to the control
( pb0.05).
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prior to the test compound. The criteria for establishing induction of the MPT
were a decrease in light scattering of at least 0.5 absorbance units 6 min post
addition of test compound and that this is inhibited completely by 1 μM CsA.
The concentrations of FOSAA and N-EtFOSAA required to induce mitochon-
drial swelling were established in previous reports (Starkov and Wallace, 2002;
O'Brien and Wallace, 2004; O'Brien et al., 2006).
Mitochondrial respiration. Mitochondria were suspended at a concentration of
0.5 mg protein/ml in 150 mM KCl, 5 mM KH2PO4, 5 mM Tris–MOPS, (pH 7.4)
supplemented with 2 μM rotenone and 1 μM CsA, and oxygen concentrationwas measured as previously described (Custodio et al., 1998; Starkov and
Wallace, 2002). To eliminate the potential of the confounding influence ofMPT
induction all respiration experiments were performed in a calcium free media
supplemented with CsA. Following are the specific methods describing the
inhibition of FOSAA and N-EtFOSAA stimulated respiration by the ANT
ligands cATR and BKA and the inhibition of ADP-stimulated respiration by the
test compounds.
Inhibition of FOSAA and N-EtFOSAA initiated uncoupled respiration.
Freshly isolated mitochondria were energized with 5 mM succinate for 1 min.
Oxygen tension was monitored continuously until state-4 respiration stabilized,
Fig. 2. FOSAA and N-EtFOSAA induced swelling of rat liver mitochondria was monitored by light scattering at 540 nm in the presence and absence of 75 μMADP or
1 μM CsA. (A) Mitochondrial swelling traces are representative of 3 repetitions, each using mitochondrial preparations from separate animals. 5 μM cATR±ADP;
40 μM FOSAA±ADP; 6 μM N-Et-FOSAA±ADP. (B) Calcium, cATR, FOSAA, and N-EtFOSAA induced a decrease in absorbance measured at 540 nM. Results
reported as change in arbitrary absorbance units 6 min after the addition of the test compound. The concentrations and additions are as reported in panel A. Bars
represent the mean±S.E.M. of 3 repetitions each analyzed by 2-way ANOVA and Tukey's post hoc test. (⁎) Statistically significant difference compared to the
treatment ( pb0.05).
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FCCP was added to initiate uncoupled respiration. The concentrations of the test
compounds for this assay were chosen to initiate a clearly measurable respiratory
uncoupling at a rate of oxygen consumption that was closely equivalent between
test compounds and 1 μM FCCP (the positive control for mitochondrial un-
coupling). After uncoupling was initiated and sustained for at least 2 min, 5 μM
of the ANT ligands cATR or BKA was added. Approximately 2 min after the
addition of cATR or BKA, 1 μMFCCPwas added in order to terminate the assay
and to verify that mitochondrial respiratory capacity was still functional after the
treatments.Inhibition of ADP-stimulated (state-3) respiration. State-3 respiration was
measured in the presence and absence of 25 μM FOSAA, 6 μM N-EtFOSAA,
8 μM oleic acid, or 5 μM cATR to determine if there is an inhibition of ADP-
stimulated respiration by FOSAA, N-EtFOSAA, or oleic acid that was not
strictly the result of Δψ depolarization induced by the test compound. This
distinction is critical to understanding the nature of the interaction between the
test compounds and the ANT. At higher concentrations, a model uncoupling
agent such as FCCP can inhibit ADP-stimulated respiration by means of
decreasing Δψ. Therefore, the concentrations of the test compounds chosen
were such that the ADP-stimulated respiration was not masked by the test
Fig. 3. Freshly isolated mitochondria were energized with 5 mM succinate for 1 min at which point 40 μM FOSAA, 10 μM N-EtFOSAA, 8 μM oleic acid, or 1 μM
FCCP was added to initiate uncoupled respiration. Panels A and B are representative tracings of the method. All measurements were performed in the presence or
absence of the ANT ligands (C) 5 μM cATR or (D) 5 μM BKA. Bars represent the mean±S.E.M. of 3 repetitions each analyzed by Student's t-test. (⁎) Statistically
significant difference compared to the treatment prior to the addition of the ANT ligand ( pb0.05).
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control for direct interaction with the ANT. Approximately 2 min after the
addition of ADP, 1 μM FCCP was added in order to terminate the reaction.
Measurement of mitochondrial membrane potential using TPP+. TPP+
selective electrode was prepared as described by Kamo et al. (1979). Changes in
Δψ of rat liver mitochondria were measured by a tetraphenylphosphonium ion
(TPP+) sensitive electrode. Briefly, 0.5 mg protein/ml was incubated at 30 °C in a
buffered solution of 175mM sucrose, 50mMKCl, 10mMMOPS, 1mMKH2PO4,
10μMEGTA in the presence of 2μMTPP+, and supplementedwith 2μMrotenone,
1 μg/ml oligomycin, and 1 μM of CsA. Results are reported in millivolts, which
were calculated as described (Drachev et al., 1975; Muratsugu et al., 1977; Kamo
et al., 1979). To eliminate the potential of the confounding influence of MPT
induction all measurements ofmitochondrialmembrane potential were performed in
a calcium free medium supplemented with CsA. Following are the specific methods
describing the inhibition of ADP-induced depolarization by the test compounds and
the BKA inhibition of the depolarization induced by the test compounds.
Inhibition of ADP-induced depolarization. Freshly isolated mitochondria
were pre-incubated in the presence of 30 μM FOSAA, 6 μM N-EtFOSAA,
5 μM oleic acid, 5 μM cATR, 0.6 μM FCCP, or a DMSO control and then
energized with 5 mM succinate for 1.5 min before adding 50 μM ADP. ADP-
induced depolarization describes the change and recovery in Δψ upon addition
of ADP. The amplitude of depolarization induced by ADP was measured in the
presence and absence of the test compounds. The purpose of this assay was to
determine if there is an inhibition of ADP-induced depolarization by FOSAA,
N-EtFOSAA, or oleic acid that was not due to the effect of the compounds on
mitochondrial Δψ. Therefore, the concentrations of the test compounds, oleic
acid, and FCCP chosen were such that the ADP-induced depolarization was not
masked by the test compound uncoupling effect. Carboxyatractyloside was used
as a positive control for direct ANT inhibition. The concentration of 0.6 μM
FCCP was established by titration to produce a rate of uncoupling comparable to
that observed in the presence of the test compounds, which was not enough to
induce a complete collapse of Δψ. FCCP was used to measure the effect that
uncoupling alone had on ADP-induced depolarization.
BKA inhibition of FOSAA and N-EtFOSAA stimulated depolarization.
Freshly isolated mitochondria were energized using 5 mM succinate and were
allowed to stabilize at maximum membrane potential for 2 min. After Δψ was
stabilized 6 μM FOSAA, 3 μM N-EtFOSAA, 3 μM oleic acid, or 0.6 μM FCCP
was added to stimulate membrane depolarization. Carboxyatractyloside was
used as a positive control for ANT inhibition. The purpose of this assay was to
measure fatty acid translocation via the ANT. Therefore, rather than mask the
effect of the fatty acid cycling process with an overwhelming dose of free fatty
acids on the first pass through the membrane, we used a lower concentration of
the test compounds to more subtly measure the component of the initial depo-
larization that is a result of this recycling process. The amplitude of this im-
mediate depolarization by the test compounds was measured in the presence and
absence of the ANT ligand 15 μM BKA.
ATPase activity. ATPase activity was determined by measuring the pH
change associated with ATP hydrolysis (Madeira et al., 1974). Freshly isolated
mitochondria were freeze-fractionated by rapidly freezing the preparation in
liquid nitrogen and thawing under warm water 3 times. One milligram of freeze-
fractionated mitochondrial protein was incubated in 2 ml of reaction media
containing 130 mM sucrose, 50 mM KCl, 5 mMMgCl2, 0.5 mM HEPES (at pH
7.2), supplemented 2 μM rotenone. The reaction was initiated with the addition
of 3 mM Mg-ATP followed by 2 μg oligomycin/mg, 8 μM oleic acid, 40 μM
FOSAA, 6 μM N-EtFOSAA, 5 μM carboxyatractyloside, or DMSO. H+ pro-
duction was determined as a change in pH measured with a Fischer Scientific
AB 15 pH meter. The addition of 2 μg oligomycin/mg protein abolished H+
production, which was calculated after 3 min of elapsed time.
Statistical analysis. All experiments were repeated using freshly isolated
hepatic mitochondria from at least three separate animals. Where indicated the
results were analyzed by 2-way ANOVA and Tukey's post hoc test, or a Stu-
dent's t-test. A probability of pb0.05 was used as the criterion for statistical
significance.Results
We have previously established that on average a concen-
tration of 25 μM calcium (50 nmol/mg protein) as an amount
that is below the calcium loading capacity of control mito-
chondria, yet sufficient to support induction of the MPT in
response to selected inducing agents (data not shown) (O'Brien
and Wallace, 2004; O'Brien et al., 2006).
Mitochondrial swelling
Calcium-dependent, CsA-inhibited mitochondrial swelling
measured by light scattering at 540 nM is a characteristic measure
of MPT induction (Haworth and Hunter, 1979; Bernardi et al.,
1992). The objective of the mitochondrial swelling assay was to
further develop an understanding of the interaction of the test
compounds with the ANT by measuring calcium-dependent
mitochondrial swelling in the presence and absence of the ANT
ligand BKA. Fig. 1A illustrates the typical experimental run
for testing the effects of the N-acetyl perfluorooctane sul-
fonamides (FOSAA and N-EtFOSAA) and the known MPT
inducer oleic acid in the presence and absence of BKA. In panel
B, repetitions of these experiments are summarized statistical-
ly. The results reported in Fig. 1 demonstrate that BKA effec-
tively inhibits FOSAA, N-EtFOSAA, or oleic acid induced
MPT. Fig. 2A shows that 40 μM FOSAA, 6 μM N-EtFOSAA,
or 5 μM cATR induces mitochondrial swelling. In the case of
FOSAA and N-EtFOSAA swelling is inhibited by ADP. Swell-
ing induced by cATR is not inhibited by ADP, but it is by CsA.
In Fig. 2B ADP inhibits mitochondrial swelling induced by
50 μM calcium, 40 μM FOSAA, and 6 μM N-EtFOSAA. In
contrast, ADP does not inhibit mitochondrial swelling induced
by 5 μMcATR. CsA completely protects against cATR induced
mitochondrial swelling (Fig. 2), as well as in every other case
depicted in Fig. 2 CsA inhibits mitochondrial swelling (data not
shown or previously reported).
Mitochondrial respiration
In an attempt to more clearly characterize the disruption of
respiration by N-acetyl perfluorooctane sulfonamides we mea-
sured test compound stimulated mitochondrial oxygen con-
sumption in the presence and absence of the ANT ligands BKA
or cATR (Fig. 3). In order to ensure that we were not observing
the effects of the MPT, all respiration work was performed in the
absence of calcium and in the presence of CsA. Figs. 3A and B
are representative tracings of mitochondrial oxygen consump-
tion stimulated by 40 μM FOSAA, which is inhibited by BKA
or cATR and yet further stimulated with 1 μM FCCP (demon-
strating that the mitochondrial respiratory chain was not inhi-
bited). All compounds were tested in the same fashion. In
Figs. 3C and D we quantitatively report the results of three
separate experiments in which cATR and BKA inhibit test
compound stimulated respiration, whereas the same ANT li-
gands do not inhibit FCCP stimulated uncoupling.
After observing that both BKA and cATR inhibit mitochon-
drial oxygen consumption stimulated by the test compounds our
Fig. 4. Freshly isolated mitochondria were incubated in the presence of the test compound or DMSO for 1 min prior to the addition of 5 mM succinate followed
approximately 2 min later with the addition of 100 μM ADP. (A) DMSO control; (B) 5 μM cATR; (C) 8 μM oleic acid; (D) 25 μM FOSAA; (E) 6 μM N-EtFOSAA;
traces are representative of 3 repetitions, each using mitochondrial preparations from separate animals. (F) Results reported as ADP-stimulated respiration in
nanoatoms oxygen/mg protein/minute. Bars represent the mean±S.E.M. of 3 repetitions each analyzed by Student's t-test. (⁎) Statistically significant difference
compared to the control ( pb0.05).
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stimulated respiration in the presence of the test compound as
compared to the solvent control and the positive control cATR.
Figs. 4A–E show the inhibition of ADP-stimulated respiration
by FOSAA, N-EtFOSAA, and oleic acid. In Fig. 4F we quan-
tify this inhibition by reporting ADP-stimulated respiration rate
in nmol O/mg/min for three separate experiments. As was ex-
pected, 5 μM cATR completely inhibits ADP-stimulated re-
spiration because presumably it inhibits translocation of ADPacross the inner mitochondrial membrane. The data show that
FOSAA, N-EtFOSAA, or oleic acid inhibits ADP-stimulated
respiration as well. However, as is the case of MPT induction,
FOSAA is also a less potent inhibitor of ADP-stimulated re-
spiration than N-EtFOSAA. The difference in potency between
these compounds throughout is likely due to the fact that FOSAA
is a charged species as a result of the unsubstituted site on the
amide. The greater ionic character of FOSAAwould make it less
membrane soluble.
Fig. 5. ADP-stimulated depolarization ofΔψ.Δψ of rat liver mitochondria was measured by a TPP+ sensitive electrode and results reported in millivolts. Mitochondria
were incubated for approximately 1 min with the indicated test compound prior to the addition of succinate. Where indicated, ADP was added at the final concentration
of 50 μM. (A) DMSO control; (B) 0.6 μMFCCP; (C) 5 μM oleic acid; (D) 6 μM N-EtFOSAA; (E) 30 μM FOSAA; and (F) 5 μM cATR. Traces are representative of 3
repetitions, each using mitochondrial preparations from separate animals. (G) Inhibition of ADP-stimulated depolarization. Bars represent the mean±S.E.M. of the
maximum depolarization for 3 repetitions each analyzed by 2-way ANOVA and Tukey's post hoc test. (⁎) Statistically significant difference compared to DMSO
control ( pb0.05).
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pounds there remains residual respiratory capacity as depicted
by the stimulation of respiration by FCCP to terminate each test
(Figs. 4B–E).
Mitochondrial membrane potential (Δψ)
Figs. 5A–F illustrate a typical experiment for measuring the
effects of 30 μM FOSAA, 6 μM N-EtFOSAA, 5 μM oleic acid,5 μM cATR, or 0.6 μM FCCP on 50 μM ADP-stimulated
depolarization and recovery of Δψ. In order to ensure that there
was no confounding influence of the MPT each assay was
performed in the absence of Ca2+ and in the presence of CsA. In
each case mitochondria were pre-incubated in the presence of
the test compound for 1 min prior to being energized with
succinate. AfterΔψ reached its maximum and maintained for at
least 1 min 50 μM ADP was added. The amplitude of depo-
larization is reported as ADP-induced depolarization (panel G).
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ADP results in a (+)30 mV depolarization of Δψ. This depo-
larization occurs immediately upon addition of ADP followed
by complete recovery to the initial membrane potential within
30 s of addition (Fig. 5A). In the presence of the cATR there is
no ADP-induced depolarization (Fig. 5F). In the presence of the
FOSAA, N-EtFOSAA, or oleic acid, ADP-stimulated depolar-
ization (Figs. 5D and E) is significantly less than control. To
establish whether this decrease in the depolarization induced
ADP was not simply the result of the uncoupling effect of the
carboxylic acids, we performed the same test in the presence of
the potent mitochondrial uncoupling agent FCCP. In contrast to
the test compounds 0.6 μM FCCP did not significantly alter
ADP-induced depolarization (Fig. 5B). In Fig. 5G we quan-
titatively report the results of three separate measures of ADP-
stimulated depolarization in the presence of the test compounds.Fig. 6. Test compound-induced change in Δψ as measured by a TPP+ sensitive elec
Experimental conditions are as reported in Fig. 5. 1 μMFCCP was added to terminate
addition of 6 μMFOSAA. B) The inhibition of phase 1 depolarization induced by 6 μ
stimulated phase 1 depolarization. Results are reported in millivolts change in Äψ as
FOSAA, 3 μM N-EtFOSAA, or 0.6 μM FCCP in the presence and absence of 15 μ
Student's t-test. (⁎) Statistically significant difference compared to the treatment (pbOleic acid as well as the test compounds induce a partial (15–
25) millivolts change inΔψ that precedes induction of the MPT,
which can be inhibited by the addition of the ANT inhibitor BKA
(Polcic et al., 1997). Having observed BKA and cATR inhibit
test compound stimulated respiration, and test compound in-
hibition of ADP-stimulated respiration, our next objective was to
determine if BKA inhibits this initial partial depolarization of
Δψ. Fig. 6 illustrates the typical experiment where 6 μM
FOSAA induced depolarization (Fig. 6A) is inhibited by BKA
(Fig. 6B). In Fig. 6C we quantitatively present data from three
separate experiments in which BKA inhibits depolarization
stimulated by 6 μM FOSAA, 3 μM N-EtFOSAA, and 3 μM
oleic acid. However, a comparable depolarization stimulated by
0.6 μMFCCP was not inhibited by BKA. Although these results
are not as dramatic as those reported by Polcic et al. (1997), they
do indicate that a component of this initial depolarization is atrode. Panels A and B are presented as representations of the measured effect.
each experiment. A) Phase 1 depolarization is the immediate change inΔψ upon
M FOSAA in the presence of 15 μMBKA. C). BKA inhibition of test compound
measured by a TPP+ sensitive electrode upon addition of 3 μM oleic acid, 6 μM
M BKA. Bars represent the mean±S.E.M. of 3 repetitions of each analyzed by
0.05).
Fig. 7. ATPase activity was determined by measuring the pH change associated with ATP hydrolysis. The reaction was initiated with the addition of 3 mMMg-ATP in
the presence of 2 μg oligomycin/mg, 8 μM oleic acid, 40 μM FOSAA, 6 μM N-EtFOSAA, 5 μM cATR, or DMSO (control). H+ production is reported as nmol/mg
protein/min after 3 min of elapsed time from the initiation of the reaction. Bars represent the mean±S.E.M. of 3 repetitions each analyzed by 2-way ANOVA and
Tukey's post hoc test. (⁎) Statistically significant difference compared to DMSO treated control ( pb0.05).
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with the ANT.
ATPase activity
In order to demonstrate that the observed inhibition of ADP-
induced depolarization of Δψ and ADP-stimulated respiration
was not a result of an inhibitory interaction of the F1/Fo ATPase
we investigated ATPase activity by measuring the pH change
associated with ATP hydrolysis in freeze-fractionated mito-
chondria. In Fig. 7 we present the results of three separate
experiments in which the pH change in the presence of 5 μM
oleic acid, 40 μMFOSAA, 6 μM N-EtFOSAA, and 5 μM cATR
was no different than the solvent control, whereas the positive
control 2 μg oligomycin/mg mitochondrial protein inhibits ATP
hydrolysis almost completely. The data show that there is no
inhibition of ATPase activity in the presence of the test
compounds or cATR.
Discussion
The purpose of this investigation was to identify the specific
initial targets responsible for disruption of mitochondrial bio-
energetics prior to the induction of the MPT by N-acetyl perfluo-
rooctane sulfonamides and if in fact this mechanism includes an
interaction with the adenine nucleotide translocator. Our previous
work (Starkov and Wallace, 2002; O'Brien and Wallace, 2004;
O'Brien et al., 2006) suggests that the mechanism of action of the
test compounds resembles that of non-fluorinated long-chain fatty
acids. Therefore, non-esterified long-chain carboxylic acids such
as oleic acid are good mechanistic models. However, the per-
sistent, non-metabolizable character of the perfluorooctane sul-fonamides suggests that there must be a measure of caution taken
in making this comparison when it comes to understanding the
in vivo pathologies.
There have been a variety of studies regarding the mech-
anism by which fatty acids disrupt mitochondrial bioenergetics.
Induction of the MPT by non-esterified fatty acids appears to be
a multifaceted mechanism that involves a series of several cri-
tical events. One event by itself may not result in the perme-
ability transition but could have a significant impact on overall
metabolic status. Petronilli and Bernardi hypothesized that fatty
acid induced MPT is a result of proton translocation across the
inner mitochondrial membrane which lowers Δψ to a critical
MPT gating potential (Petronilli et al., 1994; Bernardi et al.,
2002). Other proposed mechanisms include the cycling of mo-
novalent cations other than protons caused by fatty acid dis-
ruption of membrane integrity, again resulting in a membrane
potential-dependent triggering of mitochondrial swelling
(Schonfeld et al., 2000). It has been proposed that these mech-
anisms require the ionized fatty acid be shuttled back to the
inner membrane space through a process that apparently in-
volves mitochondrial anion transporters such as the ANT
(Skulachev, 1991) or dicarboxylate carrier (Schonfeld et al.,
1997; Wieckowski and Wojtczak, 1997).
The results of this investigation demonstrate that a direct
interaction with the ANT by N-acetyl perfluorooctane sulfona-
mides begins with an initial uncoupling of oxidative phosphor-
ylation, followed by an inhibition of ADP translocation, and
eventually ends with induction of the MPT. The nature of the
interaction between the test compounds and the ANT is revealed
by the following findings: (1) Calcium-dependent mitochon-
drial swelling induced by the test compounds or oleic acid is
inhibited by the ANT ligands BKA and ADP (Figs. 1 and 2).
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induction, there is an immediate, partial depolarization of Δψ
induced by the test compounds (O'Brien et al., 2006), which is
inhibited by BKA (Fig. 6). These results reflect those reported
by Polcic's group in which oleic acid mediated depolarization
was inhibited by BKA (Polcic et al., 1997). The fact that this
initial depolarization is inhibited by BKA provides further evi-
dence that the ANT plays a role in fatty acid, and specifically,
N-acetyl perfluorooctane sulfonamide induced uncoupling.
(3) Phase-1 depolarization predictably stimulates an increase
in mitochondrial respiration (Fig. 3). This uncoupling effect of
the perfluorinated carboxylic acids and oleic acid is again
inhibited by ligands of the ANT, whereas the uncoupling effect
of FCCP is not inhibited by either BKA or cATR (Fig. 3).
(4) Upon addition of ADP to energized mitochondria there are
two specific observable effects: stimulation of respiration, and a
rapid, partial depolarization of Δψ, followed by an equally
rapid recovery of Δψ to its initial energetic state. We show that
both of these ADP-stimulated effects are inhibited by the test
compounds (Figs. 4 and 5). (5) The observed inhibition of ADP-
stimulated respiration is not an artifact of an inhibition of the
ATPase (Fig. 7). Related to the previous observations, it is also
important to note that the uncoupling effect by the N-acetyl
perfluorooctane sulfonamides reported here is not the result of
the permeability transition as demonstrated by the fact that
this was observed in calcium free media supplemented CsA.
The maximum concentrations of the N-acetyl perfluorooc-
tane sulfonamides used in this study are higher than those
currently observed in animal or human serum samples (FOSAA;
approximately 22 ppm, and N-EtFOSAA; approximately
3.2 ppm compared to the level PFOS concentration of 12 ppm
in humans). Significant to this work is in vivo partitioning of the
perfluorooctanes to proteins in the liver and serum, and serum
half-lives in mammals which have been reported to extend to
years (Lehmler, 2005). The potential of long-term exposures
raises concern regarding the possible accumulation of perfluor-
ooctanes in membrane structures and possible interactions with
membrane proteins such as the ANT in mitochondria.
Efficient functioning of the ANT is ultimately dependent
upon mitochondrial membrane potential. The exchange of
ADP for ATP results in a depolarization of Δψ. Therefore, it is
important to distinguish which components of the observed
inhibition of the ANT are a result of the uncoupling effects of
the perfluorinated carboxylates, and which are the result of a
specific, direct interaction with the ANT. We approached this
question by utilizing two control compounds: FCCP as a classic
uncoupling agent and cATR a specific ligand of the ANT that
inhibits ADP translocation and induces the MPT. The data show
that FCCP uncoupling is not inhibited by ligands of the ANT
(Fig. 3) whereas ANT ligands do inhibit uncoupling by the
perfluorinated compounds. Furthermore, when ADP-stimulated
respiration is inhibited by the test compounds, the uncoupler
FCCP is still able to further stimulate respiration (Fig. 4). This
second measure shows that there remains respiratory capacity
(membrane proton-motive force) in mitochondria exposed to
the test compounds at the concentrations used in this study. It
should be noted, however, that in every case ADP-stimulatedrespiration is not completely inhibited by the test compounds
unlike the inhibition observed in the presence of cATR (Figs. 4
and 5). Furthermore, ADP inhibits mitochondrial swelling in-
duced by the test compounds, but not swelling induced by
cATR (Fig. 2).
These data indicate that there are several important facets to
the mechanism resulting in the disruption of mitochondrial
bioenergetics by the N-acetyl perfluorooctane sulfonamides. We
have previously focused solely on the induction of the MPT as
the target of the test compounds and the subsequent initiation of
reactive oxygen species generation and the release of cyto-
chrome c as the critical outcome of exposure to the perfluo-
rinated sulfonamido acetates (O'Brien andWallace, 2004). Each
component of this sequence following the induction of MPT
may play a significant role in the observed in vivo pathologies,
but the present findings suggest that the inhibition of the
translocation of ADP mediated by the ANT is quite possibly the
more significant and critical event leading to the toxicological
outcomes.
There is still a considerable amount of debate as to the extent
and nature of MPT induction in vivo, primarily because of the
inhibitory effect of endogenous adenine nucleotides such as
ADP. The data herein suggest that the sequence of events
leading to MPT induction in isolated mitochondria may in fact
be more important to understanding reported pathologies of
altered lipid metabolism, hepatocellular hypertrophy and vacuo-
lation, decreased serum cholesterol and triglycerides, hepato-
megaly, and decreased body weight.
These findings taken on whole allow us to propose that there
is a bimodal mechanism of action of the N-acetyl perfluorinated
sulfonamides. The first component is the initial, partial, and
ANT-mediated depolarization of Δψ that results from charge
translocation across the inner mitochondrial membrane, which
eventually leads to the induction of the MPT. The second com-
ponent is a direct interaction by N-acetyl perfluorooctane sulfo-
namides with the ANT. This interaction results in the inhibition
of ADP translocation across the inner mitochondrial mem-
brane with the ultimate outcome being the suppression of
oxidative phosphorylation. Unlike cATR, which prevents ADP
from binding the ANT cytosolic facing binding site (Pebay-
Peyroula et al., 2003), the N-acetyl perfluorooctane sulfona-
mides do not inhibit ADP binding, but rather inhibit ADP trans-
location into the matrix. Previously reported findings implicated
induction of the MPT as the critical event in the pathogenesis of
N-acetyl perfluorooctane sulfonamides. In actuality, induction of
the MPT and inhibition of the ANT may or may not be inter-
dependent and theymight occur simultaneously. Regardless, one
or both of these events may be principally responsible for the
pathogenesis observed in vivo.
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